Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial
Background/Objectives: Dendrimer-based astodrimer sodium nasal spray was assessed for its ability to reduce SARS-CoV-2 load in outpatients with COVID-19, which remains a severe illness for vulnerable groups. Methods: This was a randomised, double-blind, placebo-controlled clinical investigation eval...
Wedi'i Gadw mewn:
Prif Awduron: | Stephen Winchester (Awdur), Alex Castellarnau (Awdur), Kashif Jabbar (Awdur), Meera Nadir (Awdur), Kapila Ranasinghe (Awdur), Xavier Masramon (Awdur), George R. Kinghorn (Awdur), Isaac John (Awdur), Jeremy R. A. Paull (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
MDPI AG,
2024-09-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
gan: Jane R. Schwebke, et al.
Cyhoeddwyd: (2021) -
Nasal saline as a placebo in a rhinosinusitis study
gan: Karadag A, et al.
Cyhoeddwyd: (2014) -
Placebo
gan: Mason, David, 1924-1974 -
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold
gan: Fazekas Tamas, et al.
Cyhoeddwyd: (2012) -
Three-weekly doses of azithromycin for Indigenous infants hospitalised with bronchiolitis: A multicentre, randomised, placebo-controlled trial
gan: Gabrielle Britt McCallum, et al.
Cyhoeddwyd: (2015)